Financhill
Sell
42

UTHR Quote, Financials, Valuation and Earnings

Last price:
$292.42
Seasonality move :
4.96%
Day range:
$290.33 - $308.10
52-week range:
$230.39 - $417.82
Dividend yield:
0%
P/E ratio:
11.89x
P/S ratio:
4.93x
P/B ratio:
2.04x
Volume:
579.5K
Avg. volume:
582.8K
1-year change:
25.02%
Market cap:
$13.1B
Revenue:
$2.9B
EPS (TTM):
$24.60

United Therapeutics SEC Filings

Company Filed Form Type Description
UTHR
United Therapeutics
05/01/2024 10-Q 10-Q filing on 05/01/2024 View Form
UTHR
United Therapeutics
11/01/2023 10-Q 10-Q filing on 11/01/2023 View Form
UTHR
United Therapeutics
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
UTHR
United Therapeutics
05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
UTHR
United Therapeutics
11/02/2022 10-Q 10-Q filing on 11/02/2022 View Form
UTHR
United Therapeutics
08/03/2022 10-Q 10-Q filing on 08/03/2022 View Form
UTHR
United Therapeutics
05/04/2022 10-Q 10-Q filing on 05/04/2022 View Form
UTHR
United Therapeutics
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
UTHR
United Therapeutics
08/04/2021 10-Q 10-Q filing on 08/04/2021 View Form
UTHR
United Therapeutics
05/05/2021 10-Q 10-Q filing on 05/05/2021 View Form
UTHR
United Therapeutics
10/28/2020 10-Q 10-Q filing on 10/28/2020 View Form
UTHR
United Therapeutics
07/29/2020 10-Q 10-Q filing on 07/29/2020 View Form
UTHR
United Therapeutics
04/29/2020 10-Q 10-Q filing on 04/29/2020 View Form
UTHR
United Therapeutics
02/26/2020 10-K 10-K filing on 02/26/2020 View Form
UTHR
United Therapeutics
10/30/2019 10-Q 10-Q filing on 10/30/2019 View Form
UTHR
United Therapeutics
07/31/2019 10-Q 10-Q filing on 07/31/2019 View Form
UTHR
United Therapeutics
05/01/2019 10-Q 10-Q filing on 05/01/2019 View Form
UTHR
United Therapeutics
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
UTHR
United Therapeutics
10/31/2018 10-Q 10-Q filing on 10/31/2018 View Form
UTHR
United Therapeutics
08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
UTHR
United Therapeutics
05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
UTHR
United Therapeutics
02/21/2018 10-K 10-K filing on 02/21/2018 View Form
UTHR
United Therapeutics
10/25/2017 10-Q 10-Q filing on 10/25/2017 View Form
UTHR
United Therapeutics
07/27/2017 10-Q 10-Q filing on 07/27/2017 View Form
UTHR
United Therapeutics
04/26/2017 10-Q 10-Q filing on 04/26/2017 View Form
UTHR
United Therapeutics
02/22/2017 10-K 10-K filing on 02/22/2017 View Form
UTHR
United Therapeutics
10/27/2016 10-Q 10-Q filing on 10/27/2016 View Form
UTHR
United Therapeutics
07/28/2016 10-Q 10-Q filing on 07/28/2016 View Form
UTHR
United Therapeutics
04/28/2016 10-Q 10-Q filing on 04/28/2016 View Form
UTHR
United Therapeutics
02/25/2016 10-K 10-K filing on 02/25/2016 View Form
UTHR
United Therapeutics
10/27/2015 10-Q 10-Q filing on 10/27/2015 View Form
UTHR
United Therapeutics
07/28/2015 10-Q 10-Q filing on 07/28/2015 View Form
UTHR
United Therapeutics
04/28/2015 10-Q 10-Q filing on 04/28/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Is Fidelity High Dividend ETF a Good Investment Now?
Is Fidelity High Dividend ETF a Good Investment Now?

Fidelity’s High Dividend ETF (FDVV) is a fund that offers…

Is Kinder Morgan Dividend Yield Worth It?
Is Kinder Morgan Dividend Yield Worth It?

Kinder Morgan (NYSE:KMI) is a major energy infrastructure company in…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock